NEXGENRX INC (NXG.CA)
CA65337X1042 - Common Stock
NEXGENRX INC
TSX-V:NXG (5/30/2024, 6:00:00 PM)
0.285
0 (0%)
Company Profile
NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. The company is headquartered in Toronto, Ontario. The company went IPO on 2006-09-14. The firm is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. The firm offers plan sponsors, administration and health benefit technology applications in a of software-as-a-service model. The Company’s products include NexSys, NexAdmin, NexPension and NexPSPAssist. The NexSys product platform provides solution and simplifies adjudication of dental, prescription drug and extended health claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. Its NexPension product is an advanced pension administration solution designed to help sponsors record and tabulate contributions for their membership group in a multi-employer environment. Its platform makes self-administration a reality.
Company Info
NEXGENRX INC
191 The West Mall, Suite 905
TORONTO ONTARIO M9C 5L5
P: 14166953393
CEO: Ronald Loucks
Employees: 0
Website: https://www.nexgenrx.com/
NXG.CA News
3 years ago - NexgenRx Inc.NexgenRx Announces Financial Results for Q3 2021 with Increased Positive EBITDA and Free Cash FlowTORONTO, ON / ACCESSWIRE / November 19, 2021 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its interim financial results for the third quarter ended September 30, 2021. Despite the continuing uncertainties resulting from the COVID-19 pandemic, the Company continued to generate increased positive EBITDA and free cash flow; operated effectively and safely through the pandemic, lowered costs, and finished the quarter with
3 years ago - NexgenRx Inc.NexgenRx Announces Expansion of Leadership TeamAddition of two senior executives, John Gray and Mark Payne to the leadership team signals continued focus on technology operations and strategic innovation partnerships TORONTO, ON / ACCESSWIRE / August 24, 2021 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the addition of two new leaders to its management team: John Gray, Vice-President, Strategic Growth Opportunities, and Mark Payne, Vice-President, IT. John Gray joins
3 years ago - NexgenRx Inc.NexgenRx Announces Financial Results for Q2 2021 With Continued Growth in Revenues and Adjusted EBITDATORONTO, ON / ACCESSWIRE / August 18, 2021 / NEXGENRX INC. (TSXV:NXG) ("NexgenRx" or the "Company") is pleased to announce its interim financial results for the second quarter ended June 30, 2021, which continue to build upon the Company's positive 2020 year-end and Q1 2021 results. Despite the continued lockdowns due to COVID-19 throughout the second quarter, the Company's Q2 revenue was $2,761,544, an increase of $356,305 (14.8%) compared to
3 years ago - NexgenRx Inc.NexgenRx Announces Annual Meeting ResultsTORONTO, ON / ACCESSWIRE / June 10, 2021 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the results of its annual and special meeting (the "Meeting") of shareholders, which was held on Thursday, June 10, 2021. The Meeting was held, in part, to deliver the annual financial statements and related management's discussion and analysis of the Company, fix and appoint the directors of the Company, appoint the Company's auditors
3 years ago - NexgenRx Inc.NexgenRx Announces Financial Results for Q1 2021 with Continued EBITDA and Net Profit GrowthTORONTO, ON / ACCESSWIRE / May 26, 2021 / NEXGENRX INC. (TSXV:NXG) ("NexgenRx" or the "Company") is pleased to announce its interim financial results for the first quarter ended March 31, 2021, which continue to build upon the Company's 2020 results, which showed record growth in both EBITDA and net profit. For Q1 2021, the Company recorded EBITDA of $693,699, representing an increase of $103,806 over same prior year
4 years ago - NexgenRx Inc.NexgenRx Announces Q3 2020 ResultsTORONTO, ON / ACCESSWIRE / November 19, 2020 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the third quarter ended September 30, 2020. Revenues of $2,651,682 were generated during the period, resulting in net income of $509,843 and EBITDA of $795,169, which represented increases of $728,561 and $674,126, respectively, over the third quarter of the prior year. Transaction
NXG.CA Twits
Here you can normally see the latest stock twits on NXG.CA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
